We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Heiq Plc | LSE:HEIQ | London | Ordinary Share | GB00BN2CJ299 | ORD GBP0.05 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 9.03 | 8.80 | 9.22 | - | 23,893 | 10:07:37 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Finance Services | 48.1M | -29.25M | -0.2081 | -0.43 | 12.69M |
Date | Subject | Author | Discuss |
---|---|---|---|
15/6/2021 08:06 | Another aquisition in antimicrobial.They want to be world leader.We have got to live with Covid they say.Gla. | geraldus | |
09/6/2021 16:42 | Nice rise today a few big trades | 2bluelynn | |
09/6/2021 10:35 | No. Sorry. | petewy | |
09/6/2021 09:55 | petewy- do you understand why progresive provides this 2 weeks after the announcemnt | ali47fish | |
09/6/2021 09:21 | A note from Progressive Equity Research on two deals: HeiQ has announced two partnership deals over the past fortnight with Alchemie Technology and Wöllner GmbH. These both deliver more sustainable and environmentally friendly solutions in different industrial sectors, namely textiles, a traditional strength of HeiQ, and industrial water circuits, representing a new market sector. | petewy | |
28/5/2021 11:16 | "petewy28 May '21 - 10:22 - 295 of 295 0 0 0 What announcement? This was two days ago: PARTNER NEWS: HeiQ and Alchemie Technology establish sustainable textile finishing partnership" The RNS was issued this morning: | impvesta | |
28/5/2021 10:22 | What announcement? This was two days ago: PARTNER NEWS: HeiQ and Alchemie Technology establish sustainable textile finishing partnership | petewy | |
28/5/2021 09:56 | Nice announcement this morning, I worked in textile dyeing once energy costs, water and effluent treatment costs are a huge overhead. | melton john | |
28/5/2021 09:51 | melton what is wtdik | ali47fish | |
26/5/2021 10:35 | I bought a few early doors, to average down. Charts showed it oversold and quite a few with more appetite for risk piling in now. L2 looks ready for a tick-up but wtfdik. | melton john | |
21/5/2021 15:43 | Jan 27, 2021 Paul Scot at 182p still wildly expensive. Now 169/170 Having studied the Progressive research note (imo) still agree with PS's opinion have not seen anything that would cause me to disagree with the above opinion - Very interesting patent and product portfolio but very little sign, to me, of massivly accelerating revenue growth - Expectations YES but (imo)Jury still out - However if next rns proves on track to beat Progressive's estimates then maybe it could fly. | pugugly | |
21/5/2021 10:19 | Scsw tip was at 181 though you’d have paid more as it jumped on the news. With any new company they have to prove they can meet their projections. If they do that or better the share price will fly, if not then it will flatline or worse. No real difference to any other company, just more volatile as there is no normal to return to. That’s a decent if overly long note. Have to hope some of their brands will be real winners | dr biotech | |
21/5/2021 09:58 | Progressive’s research exhaustive report: Valuation: Reflecting its multiple growth opportunities, HeiQ’s forecast turnover growth rate is more than double that of the average and median of our selected peer comparator (compco) group. Against the best-in-class from our peer comparator group, HeiQ‘s valuation sits at a discount of around 25% - 30% across our selected valuation metrics. for download hxxps://bdadvanced.i | petewy | |
20/5/2021 23:41 | I have this on my watchlist and waiting to pounce at some point. I guess it hasn't had any traction yet as it's not cheap (pe wise), it's lost its momentum (for now) and what the company makes is not very exciting for the "media" to write about and it doesn't have much history yet and only 1 institutional has bought (an announceable amount of stock) so far this calendar year (Amati).It's dropped under the radar (at the moment). It is a quality stock that will eventually fly. I suspect the market is waiting for some strong announcements to confirm the companies strong capabilities and potential. | simmsc | |
20/5/2021 09:36 | Was I believe tipped by SCSW at 200p so possibly stop losses kicking in and also possibly profit preservation by those who bought at float - MC of £215M and p/e over 50 call for perfection and over performance against expectation - If thee are not met likely (imo) to go into free fall. BWTHDIK. | pugugly | |
19/5/2021 14:05 | I think it’s a new prospect and not many people know about it yet | mrbeaky | |
19/5/2021 12:19 | i never understand why shares are thinly traded-what are the forces at work- if this is a good company why investors are not buying? | ali47fish | |
19/5/2021 08:33 | Well there it is. Down about 15% in a week on no news. Thinly traded shares will always be more volatile | dr biotech | |
18/5/2021 20:06 | I think the gap will get filled on the chart at 175-178 and then bounce back up so good time to top up if you're looking to buy Let's get the gap filled so it gets it out of the way ! Hate gaps on charts they always get filled ! ! | 2bluelynn | |
17/5/2021 11:25 | Ali, check out investegate.co.uk, search for Heiq which gives you the admission to trading document dated 7/12/2020 | packman8 | |
16/5/2021 10:56 | pack since when it moved to mainmarket- i was investing all this time never realised stamp duty chargeable! which segment please smallcap/ 250 footsie? andno dividend- who ?is SB | ali47fish | |
16/5/2021 10:19 | Yes,that's the way it is.Not that fond of SB. | geraldus | |
15/5/2021 22:17 | For your info geraldus this is quoted on the main market.Did you not have to pay the .5% stamp duty | packman8 | |
14/5/2021 16:43 | Few more for me today on this weakness.Have a great weekend all. | geraldus |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions